Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

biomarin pharmaceutical

POPULAR ARTICLES

BMO Kicks Off Coverage of 4 Biotech Players

BMO Kicks Off Coverage of 4 Biotech Players

Long Way to Go for Gene Therapies, 2018 Outlook Panel Says

Long Way to Go for Gene Therapies, 2018 Outlook Panel Says

BioMarin Announces Several Oral and Poster Presentations

LATEST ARTICLES

BioMarin Announces EMA Grants Accelerated Assessment for Cerliponase Alfa, Experimental Treatment for a Form of Batten Disease

Biotech Investing

Top 5 Holdings in PowerShares Dynamic Biotechnology & Genome ETF

BioMarin Provides Program Update on Vosoritide in Achondroplasia

BioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor VIII Gene Therapy for Patients with Hemophilia A

Ken Bate Joins Vanda Pharmaceuticals' Board of Directors

BioMarin's Cancer Drug Purchased by Medivation for $410 Million Upfront

Sarepta And BioMarin Work Towards an FDA Coupon

Latest News

1911 Gold Temporarily Suspends Operations at True North Complex due to Bissett Evacuation Order

Brunswick Exploration Completes Brokered Private Placement for Gross Proceeds of C$3.5 Million

Juggernaut Files for Final Approval of Oversubscribed Financing

Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results